Stock 4SG SOL-GEL TECHNOLOGIES LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Calendar Sol-Gel Technologies Ltd. Deutsche Boerse AG

Equities

4SG

IL0011417206

Delayed Deutsche Boerse AG
Other stock markets
 02:00:47 2024-06-26 EDT 		5-day change 1st Jan Change
0.795 EUR +8.90% Intraday chart for Sol-Gel Technologies Ltd. +3.92% -26.39%
05-28 Sol-Gel Technologies Gets Noncompliance Notice From Nasdaq MT
05-28 Sol-Gel Technologies Ltd. Announces Resignation of Gilad Mamlok as Chief Financial Officer, Effective September 21, 2024 CI

Chart calendar Sol-Gel Technologies Ltd.

05d0b3fa777109b546b9fc8294927._CiXAwWxFKG7StyW7kil74sIG8IayUmT9Po73VUPmFI.zFKnZELIeOXDHbLDvhjdofFRU45JjArJpItCn3huyyrMeuEwZvYl8fgwmQ~3313b660e584fdb9224dd335ae61f463

Upcoming events on Sol-Gel Technologies Ltd.

2024-08-07 Q2 2024 Earnings Release (Projected)
2024-11-06 Q3 2024 Earnings Release (Projected)
2025-03-25 Q4 2024 Earnings Release (Projected)
2025-05-08 Q1 2025 Earnings Release (Projected)

Past events on Sol-Gel Technologies Ltd.

2024-05-20 07:00 Q1 2024 Earnings Release
2024-03-13 07:00 Q4 2023 Earnings Release
2023-12-06 12:00 Investor Meeting - Key Opinion Leader
2023-11-09 07:00 Q3 2023 Earnings Release
2023-09-11 07:00 H.C. Wainwright Global Investment Conference
2023-08-10 07:00 Q2 2023 Earnings Release
2023-07-26 09:00 Annual General Meeting
2023-05-12 07:00 Q1 2023 Earnings Release
2023-03-30 08:30 H.C. Wainwright Autoimmune & Inflammatory Disease Conference
2023-03-10 07:00 Q4 2022 Earnings Release
2023-01-27 08:30 Acquisition of Patidegib by Sol-Gel Technologies Ltd Call
2022-11-10 04:00 Q3 2022 Earnings Release
2022-08-04 06:00 Interim 2022 Earnings Release
2022-06-08 08:30 Jefferies Healthcare Conference
2022-05-24 07:00 H.C. Wainwright Global Life Sciences Investment Conference
2022-05-19 09:00 Annual General Meeting
2022-05-13 07:00 Q1 2022 Earnings Release
2022-03-30 07:00 FY 2021 Earnings Release
2022-03-25 10:30 American Academy of Dermatology Meeting
2022-01-10 07:00 H.C. Wainwright BioConnect Conference

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		22,9
22,8
0.24%		8,77
8,30
5.74%		31,3
30,8
1.51%		3,88
5,68
-31.64%		1,55
1,17
32.71%
5,00

EBITDA
Million USD		Released
Forecast
Spread 		-25,1
-27,9
10.15%		-28,1
-37,2
24.54%		4,53
-2,69
268.18%		0,00
0,00
- 		0,00
0,00
-
0,00

EBIT
Million USD		Released
Forecast
Spread 		-26,0
-26,6
2.3%		-30,2
-34,7
12.92%		2,96
0,74
303.08%		-16,2
-12,6
-28.63%		-29,3
-29,2
-0.25%
-24,4

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-24,6
-24,9
1.5%		-29,3
-33,8
13.28%		3,22
1,15
180.9%		-14,9
-11,7
-27.35%		-27,2
-28,2
3.52%
-23,2

Net income
Million USD		Released
Forecast
Spread 		-24,6
-24,9
1.37%		-29,3
-33,8
13.25%		3,22
1,15
180.9%		-14,9
-11,7
-27.35%		-27,2
-27,3
0.35%
-23,2

EPS
USD		Released
Forecast
Spread 		-1,26
-1,30
3.23%		-1,30
-1,48
12.31%		0,14
0,05
180%		-0,65
-0,50
-29.14%		-1,01
-1,01
0%
-0,83

Announcement Date24/03/2004/03/2130/03/2210/03/2313/03/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales
Million USD		Released
Forecast
Spread 		20,8
17,7
17.86%		0,00
1,40
-99.79%		3,52
4,61
-23.68%		0,26
3,45
-92.44%		0,10
1,84
-94.56%		0,76
0,48
59.58%		0,59
1,55
-61.76%		0,21
0,69
-69.24%		0,45
0,27
67.1%		0,47
0,56
-16.79%
1,61


1,18


1,75


1,30

EBIT
Million USD		Released
Forecast
Spread 		14,0
9,36
49.16%		-5,95
-6,83
12.93%		-0,46
-2,36
80.36%		-3,63
-1,65
-120.23%		-6,21
-3,01
-106.11%		-10,6
-5,93
-78.99%		-6,53
-7,20
9.3%		-6,31
-6,61
4.55%		-5,41
-5,33
-1.4%		-6,71
-4,84
-38.68%
-5,64


-6,22


-5,80




Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		14,0
9,45
48.46%		-5,60
-6,82
17.91%		-0,13
-2,25
94.03%		-3,41
-1,50
-126.98%		-5,79
-2,89
-100.49%		-10,3
-5,59
-83.76%		-5,97
-6,88
13.25%		-5,71
-6,31
9.46%		-4,84
-5,08
4.85%		-6,34
-4,39
-44.51%
-5,31


-5,98


-5,58




Net income
Million USD		Released
Forecast
Spread 		14,0
9,45
48.46%		-5,60
-6,82
17.91%		-0,13
-2,25
94.03%		-3,41
-1,50
-126.98%		-5,79
-2,89
-100.49%		-10,3
-5,59
-83.76%		-5,97
-6,88
13.25%		-5,71
-6,31
9.46%		-4,84
-4,93
1.96%		-6,34
-4,39
-44.51%
-5,31


-5,98


-5,58




EPS
USD		Released
Forecast
Spread 		0,61
0,51
18.83%		-0,24
-0,29
17.24%		-0,01
-0,10
89.66%		-0,15
-0,07
-130.77%		-0,25
-0,13
-100%		-0,41
-0,22
-90.7%		-0,22
-0,26
13.73%		-0,21
-0,23
8.7%		-0,17
-0,18
2.86%		-0,23
-0,16
-43.75%
-0,19


-0,21


-0,20


-0,21

Announcement Date30/03/2213/05/2204/08/2210/11/2210/03/2312/05/2310/08/2309/11/2313/03/2420/05/24----

Upcoming sector events for Sol-Gel Technologies Ltd.

2024-07-23 VIKING THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
2024-07-24 BIOCON LIMITED: Q1 2025 Earnings Release (Projected)
2024-07-25 01:00 ARGENX SE: Q2 2024 Earnings Release
2024-07-29 RHYTHM PHARMACEUTICALS, INC.: Q2 2024 Earnings Release (Projected)
2024-07-29 NEUROCRINE BIOSCIENCES, INC.: Q2 2024 Earnings Release (Projected)
2024-07-29 CEREVEL THERAPEUTICS HOLDINGS, INC.: Q2 2024 Earnings Release (Projected)
2024-07-30 CASSAVA SCIENCES, INC.: Q2 2024 Earnings Release (Projected)
2024-07-30 SPRINGWORKS THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
2024-07-30 XENCOR, INC.: Q2 2024 Earnings Release (Projected)
2024-07-30 SAREPTA THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
More events

Past sector events for Sol-Gel Technologies Ltd.

2024-06-05 03:51 PHARMAESSENTIA CORPORATION: May 2024 Sales and Revenue Release
2024-05-17 07:00 AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release
2024-05-16 07:46 BIOCON LIMITED: Q4 2024 Earnings Release
2024-05-16 01:00 ZEALAND PHARMA A/S: Q1 2024 Earnings Release
2024-05-15 LIGACHEM BIOSCIENCES INC.: Q1 2024 Earnings Release
2024-05-15 08:05 THIRD HARMONIC BIO, INC.: Q1 2024 Earnings Release
2024-05-15 07:00 CABALETTA BIO, INC.: Q1 2024 Earnings Release
2024-05-14 TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release
2024-05-14 16:05 ENLIVEN THERAPEUTICS, INC.: Q1 2024 Earnings Release
2024-05-14 16:00 ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. SLGL Stock
  4. 4SG Stock
  5. Calendar Sol-Gel Technologies Ltd.